142 related articles for article (PubMed ID: 11852781)
1. [Therapeutic effect of gefin, a new antiviral drug, in experimental genital herpes ].
Alimbarova LM; Barinskiĭ IF; Kuz'min KK
Vopr Virusol; 2002; 47(1):34-7. PubMed ID: 11852781
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of antiviral activity of new medicinal forms of foscarnet in genital herpes in guinea pigs].
Alimbarova LM; Barinskiĭ IF; Kuz'min KK
Vopr Virusol; 1998; 43(2):82-6. PubMed ID: 9606877
[TBL] [Abstract][Full Text] [Related]
3. Treatment of acyclovir-resistant herpetic ulceration with topical foscarnet and antiviral sensitivity analysis.
Pechère M; Wunderli W; Trellu-Toutous L; Harms M; Saura JH; Krischer J
Dermatology; 1998; 197(3):278-80. PubMed ID: 9812037
[TBL] [Abstract][Full Text] [Related]
4. Topical SMIP-7.7, a toll-like receptor 7 agonist, protects against genital herpes simplex virus type-2 disease in the guinea pig model of genital herpes.
Bernstein DI; Cardin RD; Bravo FJ; Earwood J; Clark JR; Li Y; Mishra P; Li C; Nayak BP; Miller AT; Wu TY; Cooke MP; Valiante NM
Antivir Chem Chemother; 2014 Apr; 23(5):189-96. PubMed ID: 23232327
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of topical acyclovir monophosphate, acyclovir, or penciclovir in orofacial HSV-1 infections of mice and genital HSV-2 infections of guinea pigs.
Kern ER; Palmer J; Szczech G; Painter G; Hostetler KY
Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):501-13. PubMed ID: 10772730
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of polyprenyl phosphates in the experimental genital herpes model].
Narovlyansky AN; Ivanova AM; Shevlyagina NV; Didenko LV; Borovaya TG; Izmest'eva AV; Sanin AV; Pronin AV; Ershov FI
Vopr Virusol; 2015; 60(4):9-13. PubMed ID: 26665428
[TBL] [Abstract][Full Text] [Related]
7. Use of immunostimulatory sequence-containing oligonucleotides as topical therapy for genital herpes simplex virus type 2 infection.
Pyles RB; Higgins D; Chalk C; Zalar A; Eiden J; Brown C; Van Nest G; Stanberry LR
J Virol; 2002 Nov; 76(22):11387-96. PubMed ID: 12388699
[TBL] [Abstract][Full Text] [Related]
8. An immunomodulating dipeptide, SCV-07, is a potential therapeutic for recurrent genital herpes simplex virus type 2 (HSV-2).
Rose WA; Tuthill C; Pyles RB
Int J Antimicrob Agents; 2008 Sep; 32(3):262-6. PubMed ID: 18619817
[TBL] [Abstract][Full Text] [Related]
9. Effect of phosphonoformate on symptomatic genital herpes simplex virus type 2 infection of guinea pigs.
Mayo DR; Lucia HL; Hsiung GD
Intervirology; 1983; 19(1):26-32. PubMed ID: 6298142
[TBL] [Abstract][Full Text] [Related]
10. Genital herpes.
Garland SM; Steben M
Best Pract Res Clin Obstet Gynaecol; 2014 Oct; 28(7):1098-110. PubMed ID: 25153069
[TBL] [Abstract][Full Text] [Related]
11. Use of the Guinea pig model of genital herpes to evaluate vaccines and antivirals: Review.
Bernstein DI
Antiviral Res; 2020 Aug; 180():104821. PubMed ID: 32544409
[TBL] [Abstract][Full Text] [Related]
12. Management of genital herpes in HIV-infected patients.
Aoki FY
Herpes; 2001 Jul; 8(2):41-5. PubMed ID: 11867017
[TBL] [Abstract][Full Text] [Related]
13. Changes in the vaginal cytology of the guinea pig induced by herpes simplex virus.
Lucia HL; Mayo DR; Hsiung GD
Acta Cytol; 1983; 27(3):365-70. PubMed ID: 6223477
[TBL] [Abstract][Full Text] [Related]
14. Foscarnet treatment of genital infection due to acyclovir-resistant herpes simplex virus type 2 in a pregnant patient with AIDS: case report.
Alvarez-McLeod A; Havlik J; Drew KE
Clin Infect Dis; 1999 Oct; 29(4):937-8. PubMed ID: 10589917
[No Abstract] [Full Text] [Related]
15. Superior efficacy of helicase-primase inhibitor BAY 57-1293 for herpes infection and latency in the guinea pig model of human genital herpes disease.
Baumeister J; Fischer R; Eckenberg P; Henninger K; Ruebsamen-Waigmann H; Kleymann G
Antivir Chem Chemother; 2007; 18(1):35-48. PubMed ID: 17354650
[TBL] [Abstract][Full Text] [Related]
16. [Effect of L-lysine-A-oxidase on development of herpetic genital infection in guinea pigs].
Smirnova IP; Alekseev SB; Diorditsa SV; Vesa VS; Zaĭtseva IZ
Biull Eksp Biol Med; 1999 Dec; 128(12):654-6. PubMed ID: 10650465
[No Abstract] [Full Text] [Related]
17. Genital herpes.
Gupta R; Warren T; Wald A
Lancet; 2007 Dec; 370(9605):2127-37. PubMed ID: 18156035
[TBL] [Abstract][Full Text] [Related]
18. Suppression of recurrent genital herpes simplex virus type 2 infection by Rhus javanica in guinea pigs.
Nakano M; Kurokawa M; Hozumi T; Saito A; Ida M; Morohashi M; Namba T; Kawana T; Shiraki K
Antiviral Res; 1998 Jul; 39(1):25-33. PubMed ID: 9754947
[TBL] [Abstract][Full Text] [Related]
19. Oral and topical treatment of experimental HSV-1 genital herpes with (E)-5-(2-bromovinyl)-2'-deoxyuridine.
Sim IS
J Antimicrob Chemother; 1984 Aug; 14 Suppl A():111-8. PubMed ID: 6541647
[TBL] [Abstract][Full Text] [Related]
20. Civamide (cis-capsaicin) for treatment of primary or recurrent experimental genital herpes.
Bourne N; Bernstein DI; Stanberry LR
Antimicrob Agents Chemother; 1999 Nov; 43(11):2685-8. PubMed ID: 10543747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
